A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Clinical trial NCT05868265 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05868265
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2027-06-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.